Led by HV Capital, with Highland Europe joining as key investor, DST Global, and existing investors Cathay Innovation and Tony Fadell's Build Collective, the funding brings Nabla's total raise to $120 million. The new capital will accelerate product development, fuel growth across Nabla's technical, clinical, and go-to-market teams, and support strategic partnerships to expand into new care settings and deliver impact at a national scale.

Nabla is on a mission to restore the human connection at the heart of healthcare through industry-leading clinical AI that optimizes clinical and financial workflows. Its assistant helps clinicians generate high-quality notes in seconds through ambient documentation, dictation, and real-time coding support. Nabla integrates with all major EHRs, supports more than 35 languages, and is used across over 130 health systems and provider groups.

The company is evolving into an adaptive agentic platform that supports a wider range of clinical workflows, care settings, and provider roles, empowering clinicians to dedicate more time to patient care.